Biomind Labs (OTC:BMNDF) Stock, Quote.Headers.trade-ideas

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Cannabis

News

Penny Stocks

Psychedelics

Markets

BMNDF

Psychedelics R&amp;D biotech Biomind Labs Inc.

New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer&#39;s

AGNPF

CMND

CMPS

CYBN

KONEF

MSSTF

MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC.

MYCOF

PSIL

PSYK

REUN

RVLWF

TSLA

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy



Psyched: Musk&#39;s Empathy Tweets, Psychedelics In Congress, Oregon&#39;s Opt-Outs, MAPS&#39; MDMA Trial And More

Earnings

Next-gen psychedelics developer Biomind Labs Inc.

Biomind Labs: Q3 Financials &amp; FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression

Biomind Labs Inc

Biotech

Press Releases

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

Biomind Labs

Comments

Biomind Labs

Biomind Labs (OTC:BMNDF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell